Therapeutic potential of stem cell-derived small extracellular vesicles for mandibular cartilage repair

Temporomandibular joint (TMJ) disorders affect millions of people, causing pain, reduced mobility, and difficulties with everyday activities such as chewing and speaking. Current treatments tend to focus on symptom relief rather than repairing the underlying cartilage damage. Our study explores an innovative, cell-free approach to address this challenge by harnessing the healing potential of tiny particles known as small extracellular vesicles, which are released by stem cells. These vesicles carry proteins and genetic materials that promote tissue repair and help reduce inflammation. We investigate vesicles derived from both TMJ cartilage stem cells and bone marrow stem cells, comparing their abilities to support cartilage repair. Our research involves detailed laboratory experiments and animal studies that closely mimic human TMJ conditions. By comparing the data between the rabbit and the human models, we aim to ensure that our findings will be relevant and translatable to future treatments for patients. This research not only expands our scientific understanding of TMJ fibrocartilage biology but also highlights the therapeutic potential of harnessing stem cell-derived small extracellular vesicles for regenerative applications. This research may lead to a therapeutic strategy that addresses both the symptoms and the underlying pathology of joint degeneration. Overall, our work represents a promising step forward in developing safe and effective regenerative therapies for TMJ disorders and other joint diseases.